Switch theme
Sign up to access all valuation multiples
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.
1998
8.2K+
LTM Revenue $8.3B
LTM EBITDA $14.6M
$2.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MicroPort Scientific has a last 12-month revenue of $8.3B and a last 12-month EBITDA of $14.6M.
In the most recent fiscal year, MicroPort Scientific achieved revenue of $122M and an EBITDA of -$49.2M.
MicroPort Scientific expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MicroPort Scientific valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $108M | $122M | XXX | XXX | XXX |
| Gross Profit | $63.2M | $64.5M | XXX | XXX | XXX |
| Gross Margin | 58% | 53% | XXX | XXX | XXX |
| EBITDA | -$47.1M | -$49.2M | XXX | XXX | XXX |
| EBITDA Margin | -44% | -40% | XXX | XXX | XXX |
| Net Profit | -$35.6M | -$56.1M | XXX | XXX | XXX |
| Net Margin | -33% | -46% | XXX | XXX | XXX |
| Net Debt | n/a | $11.4M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MicroPort Scientific's stock price is HKD 7 (or $1).
MicroPort Scientific has current market cap of HKD 12.9B (or $1.7B), and EV of HKD 18.7B (or $2.4B).
See MicroPort Scientific trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.4B | $1.7B | XXX | XXX | XXX | XXX | $-0.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MicroPort Scientific has market cap of $1.7B and EV of $2.4B.
MicroPort Scientific's trades at 2.2x LTM EV/Revenue multiple, and 1276.9x LTM EBITDA.
Analysts estimate MicroPort Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MicroPort Scientific and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.4B | XXX | XXX | XXX |
| EV/Revenue | 19.6x | XXX | XXX | XXX |
| EV/EBITDA | -48.8x | XXX | XXX | XXX |
| P/E | -26.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -43.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMicroPort Scientific's NTM/LTM revenue growth is 14%
MicroPort Scientific's revenue per employee for the last fiscal year averaged $15K, while opex per employee averaged $14K for the same period.
Over next 12 months, MicroPort Scientific's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MicroPort Scientific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MicroPort Scientific and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 13% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -40% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -27% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $15K | XXX | XXX | XXX | XXX |
| Opex per Employee | $14K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 35% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 22% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 40% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 95% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MicroPort Scientific acquired XXX companies to date.
Last acquisition by MicroPort Scientific was XXXXXXXX, XXXXX XXXXX XXXXXX . MicroPort Scientific acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MicroPort Scientific founded? | MicroPort Scientific was founded in 1998. |
| Where is MicroPort Scientific headquartered? | MicroPort Scientific is headquartered in Hong Kong. |
| How many employees does MicroPort Scientific have? | As of today, MicroPort Scientific has 8.2K+ employees. |
| Who is the CEO of MicroPort Scientific? | MicroPort Scientific's CEO is Dr. Zhaohua Chang, PhD. |
| Is MicroPort Scientific publicy listed? | Yes, MicroPort Scientific is a public company listed on HKG. |
| What is the stock symbol of MicroPort Scientific? | MicroPort Scientific trades under 00853 ticker. |
| When did MicroPort Scientific go public? | MicroPort Scientific went public in 2010. |
| Who are competitors of MicroPort Scientific? | Similar companies to MicroPort Scientific include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of MicroPort Scientific? | MicroPort Scientific's current market cap is $1.7B |
| What is the current revenue of MicroPort Scientific? | MicroPort Scientific's last 12-month revenue is $8.3B. |
| What is the current EBITDA of MicroPort Scientific? | MicroPort Scientific's last 12-month EBITDA is $14.6M. |
| What is the current EV/Revenue multiple of MicroPort Scientific? | Current revenue multiple of MicroPort Scientific is 2.2x. |
| What is the current EV/EBITDA multiple of MicroPort Scientific? | Current EBITDA multiple of MicroPort Scientific is 1276.9x. |
| What is the current revenue growth of MicroPort Scientific? | MicroPort Scientific revenue growth between 2023 and 2024 was 13%. |
| Is MicroPort Scientific profitable? | Yes, MicroPort Scientific is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
